The Chinese arm of Sequoia Capital, Sequoia China, has raised $9 billion in its new investment fund round, focusing on technology and healthcare.

  • The fund will be allocated to Sequoia Capital China Expansion Fund I, Sequoia Capital China Seed Fund III, Sequoia Capital China Venture Fund IX, and Sequoia Capital China Growth Fund VII.
  • Sequoia Global and Sequoia China have invested over $10 billion in Chinese startups since launching startups backing in China.
  • The new funding was raised from pensions, endowment funds, and family offices from Europe, the US, Southeast Asia, and the Middle East.

Why this matters?

Sequoia China's new raise is coming at a time startups in Asia, especially in China are battling funding seizure. The funding will enable the VC firm to back impact-making startups working around pharmaceuticals and healthcare, which is its core target.